A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica

Neuromyelitis optica (NMO) is a rare autoimmune disease that affects the optic nerve and spinal cord. Most NMO patients ( > 70%) are seropositive for circulating autoantibodies against aquaporin 4 (NMO-IgG+). Here, we meta-analyze whole-genome sequences from 86 NMO cases and 460 controls with genome-wide SNP array from 129 NMO cases and 784 controls to test for association with SNPs and copy number variation (total N = 215 NMO cases, 1244 controls). We identify two independent signals in the major histocompatibility complex (MHC) region associated with NMO-IgG+, one of which may be explained by structural variation in the complement component 4 genes. Mendelian Randomization analysis reveals a significant causal effect of known systemic lupus erythematosus (SLE), but not multiple sclerosis (MS), risk variants in NMO-IgG+. Our results suggest that genetic variants in the MHC region contribute to the etiology of NMO-IgG+ and that NMO-IgG+ is genetically more similar to SLE than MS.Neuromyelitis optica (NMO) is a rare autoimmune condition characterized by inflammation and demyelination of the optic nerve and the spinal cord. Here, Estrada et al. identify NMO susceptibility variants in the MHC region and find that autoantibody-positive NMO genetically overlaps with lupus.

[1]  D. Rose,et al.  X-ray crystal structure of the C4d fragment of human complement component C4. , 2002, Journal of molecular biology.

[2]  B. Weinshenker,et al.  NMO-IgG: A Specific Biomarker for Neuromyelitis Optica , 2006, Disease markers.

[3]  Brian L Browning,et al.  Genotype Imputation with Millions of Reference Samples. , 2016, American journal of human genetics.

[4]  Mauricio O. Carneiro,et al.  Scaling accurate genetic variant discovery to tens of thousands of samples , 2017, bioRxiv.

[5]  B. Weinshenker,et al.  Revised diagnostic criteria for neuromyelitis optica , 2006, Neurology.

[6]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[7]  D. Morris,et al.  Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations. , 2012, American journal of human genetics.

[8]  Mauricio O. Carneiro,et al.  From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.

[9]  Ichiro Nakashima,et al.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.

[10]  R. Handsaker,et al.  Large multi-allelic copy number variations in humans , 2015, Nature Genetics.

[11]  A. Willis,et al.  The reaction mechanism of the internal thioester in the human complement component C4 , 1996, Nature.

[12]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[13]  Giulio Genovese,et al.  Schizophrenia risk from complex variation of complement component 4 , 2016, Nature.

[14]  Patrick Vermersch,et al.  Neuromyelitis optica and non organ-specific autoimmunity. , 2008, Archives of neurology.

[15]  Bi Zhou,et al.  Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. , 2007, American journal of human genetics.

[16]  M. Papadopoulos,et al.  Aquaporin 4 and neuromyelitis optica , 2012, The Lancet Neurology.

[17]  M. Carroll,et al.  Do follicular dendritic cells regulate lupus-specific B cells? , 2014, Molecular immunology.

[18]  P. Vermersch,et al.  Is neuromyelitis optica associated with human leukocyte antigen? , 2009, Multiple sclerosis.

[19]  R. Ransohoff.  Illuminating neuromyelitis optica pathogenesis , 2012, Proceedings of the National Academy of Sciences.

[20]  Shane A. McCarthy,et al.  Reference-based phasing using the Haplotype Reference Consortium panel , 2016, Nature Genetics.

[21]  H. Shin,et al.  Common CYP7A1 promoter polymorphism associated with risk of neuromyelitis optica , 2010, Neurobiology of Disease.

[22]  E. Havrdová,et al.  Complement activation in patients with neuromyelitis optica , 2014, Journal of Neuroimmunology.

[23]  Ezequiel L. Nicolazzi,et al.  AffyPipe: an open-source pipeline for Affymetrix Axiom genotyping workflow , 2014, Bioinform..

[24]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[25]  Buhm Han,et al.  Imputing Amino Acid Polymorphisms in Human Leukocyte Antigens , 2013, PloS one.

[26]  M. Pirinen,et al.  Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis , 2013, Nature Genetics.

[27]  C. Reggiani,et al.  AQP4-Dependent Water Transport Plays a Functional Role in Exercise-Induced Skeletal Muscle Adaptations , 2013, PloS one.

[28]  E. Donadi,et al.  HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis , 2010, Multiple sclerosis.

[29]  S. Mccarroll,et al.  The genomic psychiatry cohort: Partners in discovery , 2013, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[30]  M. Krumbholz,et al.  B cells in MS and NMO: pathogenesis and therapy , 2014, Seminars in Immunopathology.

[31]  J. Rioux,et al.  Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus , 2015, Nature Genetics.

[32]  Joshua M. Korn,et al.  Discovery and genotyping of genome structural polymorphism by sequencing on a population scale , 2011, Nature Genetics.